Xiao Shui-Ming, Bai Rui, Zhang Xiao-Yan
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
College of Pharmacy and Chemistry, Dali University, Dali 671000, China.
Zhongguo Zhong Yao Za Zhi. 2016 Nov;41(22):4103-4111. doi: 10.4268/cjcmm20162204.
Gene is the base of in vivo metabolism and effectiveness for traditional Chinese medicines (TCM), and the gene expression, regulation and modification are used as the research directions to perform the TCM multi-component, multi-link and multi-target in vivo metabolism studies, which will improve the research on TCM metabolic proecess, effect target and molecular mechanism. Humans are superorganisms with 1% genes inherited from parents and 99% genes from various parts of the human body, mainly coming from the microorganisms in intestinal flora. These indicate that genetically inherited human genome and "second genome" could affect the TCM in vivo metabolism from inheritance and "environmental" aspects respectively. In the present paper, typical case study was used to discuss related TCM in vivo metabolic genomics research, mainly including TCM genomics research and gut metagenomics research, as well as the personalized medicine evoked from the individual difference of above genomics (metagenomics).
基因是中药体内代谢及药效的基础,以基因表达、调控和修饰为研究方向开展中药多成分、多环节、多靶点的体内代谢研究,将有助于深化对中药代谢过程、作用靶点及分子机制的认识。人是一个超级生物体,1%的基因来自父母遗传,99%的基因来自人体各部位,主要源于肠道菌群中的微生物。这表明遗传继承的人类基因组和“第二基因组”可分别从遗传和“环境”层面影响中药的体内代谢。本文采用典型案例研究探讨相关中药体内代谢基因组学研究,主要包括中药基因组学研究和肠道宏基因组学研究,以及上述基因组学(宏基因组学)个体差异引发的精准医学。